InvestorsHub Logo
Followers 68
Posts 2231
Boards Moderated 0
Alias Born 05/03/2013

Re: None

Sunday, 06/28/2020 3:11:50 PM

Sunday, June 28, 2020 3:11:50 PM

Post# of 40501
Did you all see this? INO is poised to run! MRNA having doubts

9 MRNA Vaccines Face Doubts After Cancer Setback -- Market Talk
10:25 am ET June 25, 2020 (Dow Jones) Print
1425 GMT - Downbeat results from tests of a cancer vaccine based on an unproven technology cast doubt over the chances of using that approach to develop coronavirus vaccines, says HSBC. The bank says data from trials of BNT-122, which uses mRNA technology and was developed by BioNTech and partner Roche Holding, showed what HSBC described as 'clearly disappointing' patient responses. HSBC says the results suggest mRNA-based vaccines may not be as immunogenic as hoped. BioNTech and partner Pfizer, as well as Moderna Inc., are developing Covid-19 vaccines based on mRNA approaches. "The failure of BNT-122 should provide pause for thought on the prospects for mRNA approaches in vaccination for COVID-19 and other diseases," HSBC analyst Steve McGarry says
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News